Work

Odronextamab plus chemotherapy in patients with previously untreated diffuse large B-cell lymphoma (DLBCL): First Results from part 1 of the Phase 3 Olympia-3 study

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-65

Authors: Jean-Marie Michot, Munci Yagci, Katherine Kargus, Hesham Mohamed, Jingxiao Chen, Jurriaan Brouwer-Visser, Aafia Chaudhry, Nazia Iqbal, Matthew Matasar

Institutions: Institut Gustave Roussy, Gazi University, Regeneron (United States), Rutgers, The State University of New Jersey, Rutgers Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417001691

Cites:

Cited by: 3

Related to: